ArticleFrontiers in oncology2020

A Chart Review on the Feasibility and Safety of the Vincristine Irinotecan Pazopanib (VIPaz) Association in Children and Adolescents With Resistant or Relapsed Sarcomas.

Ida Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.